Compositions and methods for promoting the healing of tissue of multicellular organisms
View Patent ↗Compositions are provided for promoting healing of tissue of a vertebrate organism. The compositions can be for internal administration of a therapeutically effective amount of pharmacologically active, protease inhibiting, aqueous media soluble polysulfonated materials in salt form and associated with a secondary material to reduce one or more of inflammation, bacterial proliferation, proteolytic activity, and cancerous cell growth. The compositions may additionally or alternatively be cross-linked so as to alter the solubility of these pharmacologically active salts or slow dissolution by providing biodegradable cross-linkers. Compositions for healing the tissue of a multicellular organism are provided that can include a polysulfonated material in a liquid mixture, as solid particles or constructs that may or may not biodegrade or deliver a pharmacologically relevant value. Some of the compositions are also provided for inclusion into a device for preventing infection, reducing inflammation, and preserving the activity of a protein or protein drug.
1. A composition for the healing of a multicellular organism, the composition comprising at least one polysulfonated material, the polysulfonated material being insoluble in deionized water and soluble in ion-comprising aqueous media, wherein the polysulfonated material comprises a polystyrene sulfonate, the polystyrene sulfonate comprising one or more of polystyrene arginine sulfonate, polystyrene mafenide sulfonate, silver substituted polystyrene sulfonate, chlorhexidine substituted polystyrene sulfonate, and/or doxycycline substituted polystyrene sulfonate.
2. The composition of claim 1 , wherein the polysulfonated material comprises a backbone that includes at least one repeating unit that is chiral.
3. The composition of claim 1 , wherein the polysulfonated material comprises an achiral backbone.
4. The composition of claim 1 , wherein the polysulfonated material is chiral, the chirality being imparted by a chiral pendant group substitution.
5. The composition of claim 1 , wherein the polysulfonated material further comprises at least one of a proteoglycan, the proteoglycan comprising one or more of dermatan sulfate, keratan sulfate, aggrecan, neurocan, brevican, versican, decorin, biglycan, fibromodulin, keratocan, osteoglycin and/or lumican.
6. The composition of claim 1 , wherein the polysulfonated material comprises at least two sulfonate groups modified to sulfonamides, the sulfonamides configured to cross-link at least one portion of the polysulfonated material with another portion of the polysulfonated material.
7. The composition of claim 1 , further comprising a solid matrix material.
8. The composition of claim 7 , wherein the matrix material comprises biodegradable material.
9. The composition of claim 7 , wherein the matrix material is a non-biodegradable-biomedical material comprising at least one of a silicone, a polyurethane, a polyalkylene, a hydrogel, or a polyester.
10. The composition of claim 1 , further comprising at least one of an antimicrobial agent, antibacterial metal cation, angiogenic agent, antifungal agent, antiviral agent, antiparasitic agent, anesthetic, enzyme, enzyme inhibitor, growth factor, anti-inflammatory agent, antihistamine, analgesic, antineoplastic agent, hormone, cytotoxic agent, tranquilizer, a proteoglycan, a glycosaminoglycan, silver cation, nutrient, vitamin, amino acid, nucleic acid, protein, peptide, cytokine, monoclonal antibody, and antiangiogenic agent.
11. The composition of claim 1 formulated as a gel, paste, cream, solution, ointment, or lotion.
12. The composition of claim 1 formulated as an amorphous hydrogel, the sulfonated material being blended into the hydrogel formulation.
13. The composition of claim 1 further comprising collagen or gelatin.
14. A composition for the healing of a multicellular organism, the composition comprising at least one polysulfonated material, the polysulfonated material being insoluble in deionized water and soluble in ion-comprising aqueous media, wherein the polysulfonated material comprises a chondroitin sulfate, the chondroitin sulfate comprising one or more of silver chondroitin-6-sulfate, sodium/silver chondroitin-6-sulfate, and/or arginine chondroitin-6-sulfate.